Evidence map›Paper›PMID 29941819›Full record

ArticleMolecules (Basel, Switzerland)2018

Discovery of the Potential Biomarkers for Discrimination between

Yaru Wang, Cuizhu Wang, Hongqiang Lin, Yunhe Liu, Yameng Li, Yan Zhao, Pingya Li, Jinping Liu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Sample preparation ofPharmaceutical science advances · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Comparative Analysis of Chemical Constituents ofMolecules (Basel, Switzerland) · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yaru WangSchool of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China. ywhxwyr123@163.com.
Cuizhu WangSchool of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China. wangcz15@mails.jlu.edu.cn.
Hongqiang LinSchool of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China. linhq17@mails.jlu.edu.cn.
Yunhe LiuSchool of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China. lyh133700@163.com.
Yameng LiSchool of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China. liyameng2018@163.com.
Yan ZhaoCollege of Chinese Medicinal Materials, Jilin Agriculture University, Xincheng Street 2888, Changchun 130118, China. zhaoyan@jlau.edu.cn.
Pingya LiSchool of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China. lipy@jlu.edu.cn.
Jinping LiuSchool of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China. liujp@jlu.edu.cn.ORCID 0000-0003-4020-879X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnthraquinonesBiomarkersChromatography, High Pressure LiquidFlavonoidsHedyotisIridoidsMass SpectrometryMetabolome2-hydroxy-3-methylanthraquinoneAnthraquinonesBiomarkersFlavonoidsIridoidschemical componentsHedyotis corymbosa (L.) Lam.Hedyotis diffuse Willd.metabolomic analysis

Identifiers

PMID29941819
PMCPMC6100407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.